How has been the historical performance of Dhampur Bio?

Answer:The historical performance of Dhampur Bio shows fluctuations in key financial metrics over the past four years. Breakdown: Dhampur Bio's net sales for the year ending March 2025 were reported at 1,861.54 crore, slightly down from 1,864.44 crore in March 2024 and significantly lower than 2,407.53 crore in March 2023. The total operating income mirrored this trend, remaining almost flat from the previous year but showing a decline from the prior two years. The total expenditure, excluding depreciation, was 1,726.74 crore in March 2025, a minor decrease from 1,728.01 crore in March 2024, yet lower than 2,202.81 crore in March 2023. Operating profit (PBDIT) for March 2025 was 138.46 crore, down from 160.30 crore in March 2024 and 216.14 crore in March 2023. Profit before tax also saw a decline to 15.71 crore in March 2025 from 65.49 crore in March 2024 and 134.77 crore in March 2023. Consequently, profit after tax dropped to 14.69 crore in March 2025 from 46.49 crore in March 2024 and 111.10 crore in March 2023. The company's total assets increased to 2,397.53 crore in March 2025 from 2,312.81 crore in March 2024, while total liabilities also rose to 2,397.53 crore from 2,312.81 crore in the same period. Cash flow from operating activities turned negative at -101 crore in March 2024, contrasting with a positive cash flow of 368 crore in March 2023. Overall, the financial performance of Dhampur Bio indicates a downward trend in profitability and sales over the last few years, despite an increase in total assets and liabilities.